Short-course radiation to ease symptoms from head and neck cancer
Part of Cancer clinical trials.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign informed consent
- Your cancer is squamous cell carcinoma found in the head and neck area
- Your care team says your cancer is not treatable with a cure (palliative treatment only)
- You can safely receive radiation therapy (no major reasons you can’t have it)
- You are not pregnant or breastfeeding
- You can complete recent exams, scans, and symptom/pain questionnaires before treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) specifically for older adults with head and neck cancer that has not spread. The aim is to make treatment more convenient and manageable while still being effective, potentially with fewer side effects.
This study tests a shorter course of radiation therapy (called hypofractionated radiotherapy) for people with head and neck cancer who have already had surgery to remove the tumor. It is for patients with certain 'intermediate-risk' features, aiming to improve outcomes while possibly reducing treatment time.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This study looks at using a special scan (F-MISO-PET) to see areas of low oxygen in head and neck cancer. The radiation dose is then customized to give higher doses to those low-oxygen areas, which may improve the chance of controlling the tumor.
This trial compares two types of radiation therapy to relieve symptoms from advanced head and neck cancer that cannot be cured. One is a shorter, more precise treatment (SBRT), and the other is standard radiation. The goal is to see which better improves quality of life and reduces side effects.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.